Retinalgenix Technologies Inc.
RTGN
Revenue
0.00
0.000.00%
-Assets
87.02k
▲36.50k▲72.26%
3 Months ChangeLiabilities
1.90M
▲329.00k▲20.96%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-19
Form 10-Q
ID: 0001493152-24-033012
2024-05-20
Form 10-Q
ID: 0001493152-24-020564
2024-04-08
Form 8-K
ID: 0001493152-24-013775
2023-12-06
Form 8-K
ID: 0001493152-23-043870
2023-12-04
Form 8-K
ID: 0001493152-23-043522
2023-11-14
Form 10-Q
ID: 0001493152-23-040743
2023-08-14
Form 10-Q
ID: 0001493152-23-028030
2023-05-18
Form 10-Q
ID: 0001493152-23-018123
2022-11-17
Form 10-Q
ID: 0001493152-22-032753
2022-08-19
Form 10-Q
ID: 0001493152-22-023602